FDA Investigator James E Szelc
James E Szelc has conducted inspections on 53 sites in 4 countries as of 28 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
53
Last Inspection Date:
28 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Mexico,
Malaysia
FDA Investigators that have inspected at least one site in common with James E Szelc:
Althea A Williams,
Amy S Graf,
Anthony C Taube,
Art O Czabaniuk,
Benjamin J Dastoli,
Benjamin J Smith,
Brian P Putz,
Byungja E Marciante,
Calvin K Cook,
Carolyn J Oyster,
Cathie S Marshall,
Charles M Spyr,
Cynthia L Aycock,
Cynthia Li,
Daniel W Stoll,
Darren S Morgan,
David J Gasparovich,
Deanna L Lampley,
Debara R Reese,
Dolores Harper,
Elizabeth P Kinsella,
Emily J Orban,
Eric E Joneson,
Eric S Pittman,
Evelyn Taha,
Gary Durbiel Goldner,
George G Calafactor,
Hokenson,
Jeannie M Melin,
Jeffrey D Meng,
John N Woodall,
Kelley L Clark,
Kelly R Serfling,
Kimberly Lewandowski Walker,
Kinh Q Mac,
Kristina Fillmore,
Kristina Mezin,
Kristina Nastovski,
Laureen F Kononen,
Lauren E Burke,
Lauren E Sexton,
LCDR Anastasia M Piliafas Brown,
LCDR Wilfred A Darang,
Leslie A Paul,
Lori S Lawless,
Maribeth G Grattan,
Maribeth G Niesen,
Marlon K Turner,
Matthew H Pitts,
Michael E Campbell,
Michael J Nerz,
Michael K Larson,
Michele L Forster, PhD,
Msdap Gonzlezk,
Myra K Casey,
Paige E Shelborne,
Patricia A Mcilroy,
Patrick B Cummings,
Patsy J Domingo,
Phenicia T Petty,
Rasha Bamieh,
Reginald Walker,
Richard T Riggie,
Robert G Ruff,
Roger A Hartman,
Rosanna M Goodrich,
Ryan J Benedict,
Sanket N Patel,
Sarah M Napier,
Sargum C Manley,
Sargum C Sood,
Shannon A Gregory,
Steven R Ziser,
Talmane J Fisher,
Thomas A Peter,
Tracey L Siebesma,
Twana R Chandler,
Tyra L Vanleer,
Vanessa J Colburn,
Vesa Vuniqi,
William D Tingley,
William G Nelson,
William R Brubaker
James E Szelc's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2000 | EIR | U.S. Filter/Ionpure, Inc. - EIR, 2000-09-27 |
November, 2001 | EIR | DePuy Orthopaedics, Inc. - EIR, 2001-11-30 |
September, 2000 | FDA 483 | U.S. Filter Corp. - Form 483, 2000-09-27 |
April, 2001 | EIR | SRI/ Surgical Express - EIR, 2001-04-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more